2min chapter

In Good Company with Nicolai Tangen cover image

HIGHLIGHTS: Thomas Schinecker - CEO of Roche

In Good Company with Nicolai Tangen

CHAPTER

Innovations in Drug Development and Brain Treatment

This chapter explores a pharmaceutical company's robust product pipeline and its track record of annual medicine launches. It focuses on cutting-edge brain shuttle technology aimed at overcoming the blood-brain barrier, particularly for a promising Alzheimer's treatment expected to debut in the late 2020s.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode